Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Rutherrin

<< Previous

Bullboard Posts

Next >>

Comment by patience69on Apr 17, 2022 11:55am

195 Views

Post# 34608415

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Rutherrin

Fred
No need to feel alone on the lung cancer questions. I for one have many times pondered what happened with the Roswell trial. Maybe it was a business decision on TLT's part. Maybe an upcoming partner wanted it all. Maybe our xray activation is so supreme that we would be competing with ourselves?
Your points are valid . Why do we have to guess?

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China